Insulin therapy improves islet functions by restoring pancreatic vasculature in high-fat diet-fed streptozotocin-diabetic rats

Journal of Diabetes

Volumn 6, Issue 3, 2014, Pages 228-236

  Gu, Huimin ^a   Xia, Xuan ^a   Chen, Zonglan ^a   Liang, Hua ^a   Yan, Jinhua ^a   Xu, Fen ^a   Weng, Jianping ^a  

^a THE THIRD AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

Author keywords

Insulin treatment; Microcirculation; Type 2 diabetes; cell recovery

Indexed keywords

CD31 ANTIGEN; CHOLESTEROL; GLUCOSE; INSULIN; ISOPHANE INSULIN; TRIACYLGLYCEROL; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2; ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL; VASCULOTROPIN A;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CAPILLARY DENSITY; CELL FUNCTION; CELL SIZE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DIET RESTRICTION; FOOD INTAKE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HISTOPATHOLOGY; HYPERPHAGIA; IMMUNOHISTOCHEMISTRY; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN TREATMENT; LIPID DIET; MALE; METABOLIC DISORDER; MICROVASCULATURE; NONHUMAN; PANCREAS ISLET BETA CELL; POLYDIPSIA; POLYURIA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL; WESTERN BLOTTING; ADVERSE EFFECTS; ANIMAL; BLOOD; BLOOD VESSEL; DIABETES MELLITUS, EXPERIMENTAL; DRUG EFFECTS; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET; PATHOPHYSIOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT; VASCULARIZATION;

ANIMALS; ANTIGENS, CD31; BLOOD GLUCOSE; BLOOD VESSELS; BLOTTING, WESTERN; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; DIET, HIGH-FAT; GLUCOSE TOLERANCE TEST; HYPOGLYCEMIC AGENTS; IMMUNOHISTOCHEMISTRY; INSULIN, ISOPHANE; INSULIN-SECRETING CELLS; ISLETS OF LANGERHANS; MALE; RATS; RATS, SPRAGUE-DAWLEY; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 84898599918     PISSN: 17530393     EISSN: 17530407     Source Type: Journal    
DOI: 10.1111/1753-0407.12095     Document Type: Article

References (50)

1. Turner RC, Cull CA, Frighi V, Holman RR. Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: Progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group. JAMA. 1999; 281: 2005-2012.
2. Donath MY, Storling J, Maedler K, Mandrup-Poulsen T. Inflammatory mediators and islet beta-cell failure: A link between type 1 and type 2 diabetes. J Mol Med (Berl). 2003; 81: 455-470.
3. Poitout V, Robertson R. Glucolipotoxicity: Fuel excess and beta-cell dysfunction. Endocr Rev. 2008; 29: 351-366.
4. Sustained effect of intensive treatment of type 1 diabetes mellitus on development and progression of diabetic nephropathy: The Epidemiology of Diabetes Interventions and Complications (EDIC) study. JAMA. 2003; 290: 2159-2167.
5. Pop-Busui R, Herman WH, Feldman EL etal. DCCT and EDIC studies in type 1 diabetes: Lessons for diabetic neuropathy regarding metabolic memory and natural history. Curr Diab Rep. 2010; 10: 276-282.
6. Polak JF, Backlund JY, Cleary PA etal. Progression of carotid artery intima-media thickness during 12 years in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) study. Diabetes. 2011; 60: 607-613.
7. Li Y, Xu W, Liao Z etal. Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients is associated with improvement of beta-cell function. Diabetes Care. 2004; 27: 2597-2602.
8. Weng J, Li Y, Xu W etal. Effect of intensive insulin therapy on beta-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: A multicentre randomised parallel-group trial. Lancet. 2008; 371: 1753-1760.
9. Wajchenberg BL. beta-cell failure in diabetes and preservation by clinical treatment. Endocr Rev. 2007; 28: 187-218.
10. Brown RJ, Rother KI. Effects of beta-cell rest on beta-cell function: A review of clinical and preclinical data. Pediatr Diabetes. 2008; 9(3 Pt 2): 14-22.
11. Kubota N, Terauchi Y, Tobe K etal. Insulin receptor substrate 2 plays a crucial role in beta cells and the hypothalamus. J Clin Invest. 2004; 114: 917-927.
12. Cuschieri J, Bulger E, Grinsell R, Garcia I, Maier RV. Insulin regulates macrophage activation through activin A. Shock. 2008; 29: 285-290.
13. Ghanim H, Mohanty P, Deopurkar R etal. Acute modulation of toll-like receptors by insulin. Diabetes Care. 2008; 31: 1827-1831.
14. Leibiger IB, Leibiger B, Berggren PO. Insulin signaling in the pancreatic beta-cell. Annu Rev Nutr. 2008; 28: 233-251.
15. Thorel F, Nepote V, Avril I etal. Conversion of adult pancreatic alpha-cells to beta-cells after extreme beta-cell loss. Nature. 2010; 464: 1149-1154.
16. Dewitt LM. Morphology and physiology of areas of langerhans in some vertebrates. J Exp Med. 1906; 8: 193-239.
17. Lammert E, Cleaver O, Melton D. Induction of pancreatic differentiation by signals from blood vessels. Science. 2001; 294: 564-567.
18. Bar RS, DeRose A, Sandra A, Peacock ML, Owen WG. Insulin binding to microvascular endothelium of intact heart: A kinetic and morphometric analysis. Am J Physiol. 1983; 244: E447-452.
19. Aljada A, Dandona P. Effect of insulin on human aortic endothelial nitric oxide synthase. Metabolism. 2000; 49: 147-150.
20. Aljada A, Saadeh R, Assian E, Ghanim H, Dandona P. Insulin inhibits the expression of intercellular adhesion molecule-1 by human aortic endothelial cells through stimulation of nitric oxide. J Clin Endocrinol Metab. 2000; 85: 2572-2575.
21. Reed MJ, Meszaros K, Entes LJ etal. A new rat model of type 2 diabetes: The fat-fed, streptozotocin-treated rat. Metabolism. 2000; 49: 1390-1394.
22. Bi Y, Cai M, Liang H etal. Increased carnitine palmitoyl transferase 1 expression and decreased sterol regulatory element-binding protein 1c expression are associated with reduced intramuscular triglyceride accumulation after insulin therapy in high-fat-diet and streptozotocin-induced diabetic rats. Metabolism. 2009; 58: 779-786.
23. Xia X, Yan J, Shen Y etal. Berberine improves glucose metabolism in diabetic rats by inhibition of hepatic gluconeogenesis. PLoS ONE. 2011; 6: e16556.
24. Cao S, Li B, Yi X etal. Effects of exercise on AMPK signaling and downstream components to PI3K in rat with type 2 diabetes. PLoS ONE. 2012; 7: e51709.
25. Si Y, Zhao Y, Hao H etal. Infusion of mesenchymal stem cells ameliorates hyperglycemia in type 2 diabetic rats: Identification of a novel role in improving insulin sensitivity. Diabetes. 2012; 61: 1616-1625.
26. Nicholson JM, Arany EJ, Hill DJ. Changes in islet microvasculature following streptozotocin-induced beta-cell loss and subsequent replacement in the neonatal rat. Exp Biol Med. 2010; 235: 189-198.
27. Akirav EM, Baquero MT, Opare-Addo LW etal. Glucose and inflammation control islet vascular density and beta-cell function in NOD mice: Control of islet vasculature and vascular endothelial growth factor by glucose. Diabetes. 2011; 60: 876-883.
28. Kamba T, Tam BY, Hashizume H etal. VEGF-dependent plasticity of fenestrated capillaries in the normal adult microvasculature. Am J Physiol Heart Circ Physiol. 2006; 290: H560-576.
29. Brissova M, Shostak A, Shiota M etal. Pancreatic islet production of vascular endothelial growth factor - a is essential for islet vascularization, revascularization, and function. Diabetes. 2006; 55: 2974-2985.
30. Alvarsson M, Sundkvist G, Lager I etal. Beneficial effects of insulin versus sulphonylurea on insulin secretion and metabolic control in recently diagnosed type 2 diabetic patients. Diabetes Care. 2003; 26: 2231-2237.
31. Chen HS, Wu TE, Jap TS, Hsiao LC, Lee SH, Lin HD. Beneficial effects of insulin on glycemic control and beta-cell function in newly diagnosed type 2 diabetes with severe hyperglycemia after short-term intensive insulin therapy. Diabetes Care. 2008; 31: 1927-1932.
32. Hu Y, Li L, Xu Y etal. Short-term intensive therapy in newly diagnosed type 2 diabetes partially restores both insulin sensitivity and beta-cell function in subjects with long-term remission. Diabetes Care. 2011; 34: 1848-1853.
33. Jackson RL, Boyd JD, Smith RE. Stabilization of diabetic children. Am J Dis Child. 1940; 59: 332-341.
34. Greenwood RH, Mahler RF, Hales CN. Improvement in insulin secretion in diabetes after diazoxide. Lancet. 1976; 1: 444-447.
35. Mirouze J, Selam JL, Pham TC, Mendoza E, Orsetti A. Sustained insulin-induced remissions of juvenile diabetes by means of an external artificial pancreas. Diabetologia. 1978; 14: 223-227.
36. Ritzel RA, Jayasinghe S, Hansen JB, Sturis J, Langen R, Butler PC. Beta-cell selective K(ATP)-channel activation protects beta-cells and human islets from human islet amyloid polypeptide induced toxicity. Regul Pept. 2010; 165: 158-162.
37. Jansson L, Hellerstrom C. Stimulation by glucose of the blood flow to the pancreatic islets of the rat. Diabetologia. 1983; 25: 45-50.
38. Jansson L, Andersson A, Bodin B, Kallskog O. Pancreatic islet blood flow during euglycaemic, hyperinsulinaemic clamp in anaesthetized rats. Acta Physiol. 2007; 189: 319-324.
39. Li X, Zhang L, Meshinchi S etal. Islet microvasculature in islet hyperplasia and failure in a model of type 2 diabetes. Diabetes. 2006; 55: 2965-2973.
40. Lammert E, Gu G, McLaughlin M etal. Role of VEGF-A in vascularization of pancreatic islets. Curr Biol. 2003; 13: 1070-1074.
41. Tilton RG, Kawamura T, Chang KC etal. Vascular dysfunction induced by elevated glucose levels in rats is mediated by vascular endothelial growth factor. J Clin Invest. 1997; 99: 2192-2202.
42. Lorenzi M, Nordberg JA, Toledo S. High glucose prolongs cell-cycle traversal of cultured human endothelial cells. Diabetes. 1987; 36: 1261-1267.
43. Ho FM, Liu SH, Liau CS, Huang PJ, Lin-Shiau SY. High glucose-induced apoptosis in human endothelial cells is mediated by sequential activations of c-Jun NH(2)-terminal kinase and caspase-3. Circulation. 2000; 101: 2618-2624.
44. Busik JV, Mohr S, Grant MB. Hyperglycemia-induced reactive oxygen species toxicity to endothelial cells is dependent on paracrine mediators. Diabetes. 2008; 57: 1952-1965.
45. Kageyama S, Yokoo H, Tomita K etal. High glucose-induced apoptosis in human coronary artery endothelial cells involves up-regulation of death receptors. Cardiovasc Diabetol. 2011; 10: 73.
46. Chen J, Brodsky SV, Goligorsky DM etal. Glycated collagen I induces premature senescence-like phenotypic changes in endothelial cells. Circ Res. 2002; 90: 1290-1298.
47. Ido Y, Carling D, Ruderman N. Hyperglycemia-induced apoptosis in human umbilical vein endothelial cells: Inhibition by the AMP-activated protein kinase activation. Diabetes. 2002; 51: 159-167.
48. Du J, Xu R, Hu Z etal. PI3K and ERK-induced Rac1 activation mediates hypoxia-induced HIF-1alpha expression in MCF-7 breast cancer cells. PLoS ONE. 2011; 6: e25213.
49. Poulaki V, Qin W, Joussen AM etal. Acute intensive insulin therapy exacerbates diabetic blood-retinal barrier breakdown via hypoxia-inducible factor-1alpha and VEGF. J Clin Invest. 2002; 109: 805-815.
50. Vicent D, Ilany J, Kondo T etal. The role of endothelial insulin signaling in the regulation of vascular tone and insulin resistance. J Clin Invest. 2003; 111: 1373-1380.